| 000 | 01118nam a2200349Ia 4500 | ||
|---|---|---|---|
| 001 | 007475 | ||
| 008 | 141222s9999 xx 000 0 und d | ||
| 020 | _a92-832-1279-7 | ||
| 022 | _a1017-1606 | ||
| 040 | _aDB/INS | ||
| 041 | 0 | _aeng | |
| 084 | _aWHO | ||
| 084 | _bIARC V.79 | ||
| 110 | 2 | _a10-17 Oct. 2000 | |
| 111 | 2 | _aSome thyrotropic agents | |
| 111 | 2 | _cLyon, Francia | |
| 111 | 2 | _d10-17 Oct. 2000 | |
| 245 | 1 | 0 | _aSome thyrotropic agents |
| 245 | 1 | 0 | _cWorld Health Organization, International Agency for Research on Cancer, Working group on the evaluation of carcinogenic risks to humans |
| 260 | _aLyon | ||
| 260 | _bWHO | ||
| 260 | _c2001 | ||
| 300 | _aiv, 763 | ||
| 300 | _btbls | ||
| 440 | 0 | _aIARC Working Group on the Evaluation of Carcinogenic risks to humans; 79 | |
| 500 | _aIntitución patrocinadora: International Agency for Research on Cancer | ||
| 650 | 1 | _aCarcinogenos | |
| 650 | 2 | _aCongresos | |
| 650 | 2 | _aneoplasmas de la tiroides | |
| 710 | 2 | _aInternational Agency for Research on Cancer | |
| 710 | 2 | _aWorking group on the evaluation of carcinogenic risks to humans | |
| 999 |
_c16898 _d16898 |
||